Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | PDXK | O00764 | 1/20 | 0.38 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.38 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.37 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.37 |
| ▸ | VRK1 | Q99986 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.34 |
| ▸ | TNF | P01375 | 2/20 | 0.33 |
| ▸ | SELL | P14151 | 1/20 | 0.32 |
| ▸ | SELP | P16109 | 1/20 | 0.32 |
| ▸ | SELE | P16581 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methane SCHEMBL6846367 | 0.97 | KDM4E (0.42) | KDM4EALDH1A1HPGDHSD17B10LMNA | |
| SCHEMBL7880212 | 0.81 | KDM4E (0.35) | KDM4EALDH1A1HPGDHSD17B10LMNA | |
| SCHEMBL3679226 | 0.79 | KDM4E (0.43) | KDM4EALDH1A1HPGDHSD17B10LMNA | |
| SCHEMBL31184201 | 0.79 | KDM4E (0.43) | KDM4EALDH1A1HPGDHSD17B10LMNA | |
| SCHEMBL4321859 | 0.73 | KDM4E (0.39) | KDM4EALDH1A1HPGDHSD17B10LMNA | |
| SCHEMBL12677154 | 0.72 | CYP3A4 (0.40) | KDM4EALDH1A1HPGDHSD17B10LMNA | |
| SCHEMBL16418384 | 0.72 | KDM4E (0.52) | KDM4EALDH1A1HPGDHSD17B10LMNA | |
| SCHEMBL15577964 | 0.72 | KDM4E (0.38) | KDM4EALDH1A1HPGDHSD17B10LMNA | |
| SCHEMBL1049253 | 0.72 | KDM4E (0.68) | KDM4EALDH1A1HPGDHSD17B10LMNA | |
| SCHEMBL9656230 | 0.70 | KDM4E (0.45) | KDM4EALDH1A1HPGDHSD17B10LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1852102-B1 | Method for manufacturing oil in water emulsions for roll-on applications | HENKEL AG & CO KGAA (DE) | 2016-10-05 | — | — | EP | disclosed |
| EP-2023888-B1 | QUICK-DRYING COSMETIC EMULSIONS FOR ROLL-ON APPLICATION | HENKEL AG & CO KGAA (DE) | 2015-10-07 | — | — | EP | disclosed |
| EP-2700431-A1 | Plant extracts for modulating TRPV1 function | AnalytiCon Discovery GmbH (DE) | 2014-02-26 | — | — | EP | disclosed |
| US-20110192416-A1 | USE OF HYDROPHOBIN FOR NON-PERMANENT DYEING OF KERATIN | BASF SE (DE) | 2011-08-11 | — | — | US | disclosed |
| EP-2023888-A2 | QUICK-DRYING COSMETIC EMULSIONS FOR ROLL-ON APPLICATION | Henkel AG & Co. KGaA (DE) | 2009-02-18 | — | — | EP | disclosed |
| WO-2007124889-A2 | QUICK-DRYING COSMETIC EMULSIONS FOR ROLL-ON APPLICATION | HENKEL AG & CO. KGAA (DE) | 2007-11-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110192416-A1 | USE OF HYDROPHOBIN FOR NON-PERMANENT DYEING OF KERATIN | KRT18, VIM, CD68 | KDM4E 2651/4885ALDH1A1 1762/4885HPGD 287/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.